Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224238 | SCV000281111 | likely pathogenic | not provided | 2016-04-29 | criteria provided, single submitter | clinical testing | |
3billion | RCV002283469 | SCV002573265 | pathogenic | Mitochondrial DNA depletion syndrome 13 | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with FBXL4 -related disorder (ClinVar ID: VCV000235493). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |